

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ribosomal small subunit biogenesis (GO:0042274) | 4.44913133 |
| 2 | response to peptidoglycan (GO:0032494) | 4.02260705 |
| 3 | negative regulation of endoplasmic reticulum calcium ion concentration (GO:0032471) | 3.79234906 |
| 4 | protein maturation by protein folding (GO:0022417) | 3.77840142 |
| 5 | deoxyribonucleoside monophosphate metabolic process (GO:0009162) | 3.72263457 |
| 6 | neutrophil activation involved in immune response (GO:0002283) | 3.65222898 |
| 7 | nucleobase-containing small molecule interconversion (GO:0015949) | 3.30266170 |
| 8 | viral transcription (GO:0019083) | 3.28877123 |
| 9 | regulation of superoxide anion generation (GO:0032928) | 3.17525168 |
| 10 | pentose-phosphate shunt (GO:0006098) | 3.10034735 |
| 11 | pinocytosis (GO:0006907) | 3.08910509 |
| 12 | GDP-mannose metabolic process (GO:0019673) | 3.01746613 |
| 13 | negative regulation of interleukin-12 production (GO:0032695) | 3.00865357 |
| 14 | translational termination (GO:0006415) | 3.00398645 |
| 15 | pentose metabolic process (GO:0019321) | 2.95642954 |
| 16 | pyrimidine deoxyribonucleotide catabolic process (GO:0009223) | 2.93998682 |
| 17 | ribosomal large subunit biogenesis (GO:0042273) | 2.90856321 |
| 18 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 2.87837269 |
| 19 | SRP-dependent cotranslational protein targeting to membrane (GO:0006614) | 2.87021232 |
| 20 | protein targeting to ER (GO:0045047) | 2.85197848 |
| 21 | antigen processing and presentation of exogenous peptide antigen via MHC class I (GO:0042590) | 2.78454928 |
| 22 | cotranslational protein targeting to membrane (GO:0006613) | 2.78195955 |
| 23 | pyrimidine deoxyribonucleotide metabolic process (GO:0009219) | 2.77488887 |
| 24 | deoxyribose phosphate biosynthetic process (GO:0046385) | 2.76331578 |
| 25 | 2-deoxyribonucleotide biosynthetic process (GO:0009265) | 2.76331578 |
| 26 | positive regulation by symbiont of host defense response (GO:0052509) | 2.76164873 |
| 27 | modulation by symbiont of host defense response (GO:0052031) | 2.76164873 |
| 28 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 2.76164873 |
| 29 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 2.76164873 |
| 30 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 2.76164873 |
| 31 | modulation by symbiont of host immune response (GO:0052553) | 2.76164873 |
| 32 | maturation of SSU-rRNA (GO:0030490) | 2.76109788 |
| 33 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (GO: | 2.75730649 |
| 34 | protein localization to endoplasmic reticulum (GO:0070972) | 2.74351128 |
| 35 | pyrimidine-containing compound salvage (GO:0008655) | 2.74305508 |
| 36 | pyrimidine nucleoside salvage (GO:0043097) | 2.74305508 |
| 37 | respiratory burst (GO:0045730) | 2.72099079 |
| 38 | translational elongation (GO:0006414) | 2.72049278 |
| 39 | immunoglobulin mediated immune response (GO:0016064) | 2.72034884 |
| 40 | Golgi transport vesicle coating (GO:0048200) | 2.71972773 |
| 41 | COPI coating of Golgi vesicle (GO:0048205) | 2.71972773 |
| 42 | establishment of protein localization to endoplasmic reticulum (GO:0072599) | 2.71624683 |
| 43 | glycosphingolipid catabolic process (GO:0046479) | 2.71567249 |
| 44 | NADPH regeneration (GO:0006740) | 2.69669984 |
| 45 | negative regulation of myeloid cell apoptotic process (GO:0033033) | 2.68620961 |
| 46 | NIK/NF-kappaB signaling (GO:0038061) | 2.68246831 |
| 47 | viral life cycle (GO:0019058) | 2.68150257 |
| 48 | daunorubicin metabolic process (GO:0044597) | 2.64252747 |
| 49 | polyketide metabolic process (GO:0030638) | 2.64252747 |
| 50 | doxorubicin metabolic process (GO:0044598) | 2.64252747 |
| 51 | negative regulation of release of cytochrome c from mitochondria (GO:0090201) | 2.64018048 |
| 52 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 2.63179570 |
| 53 | detection of other organism (GO:0098543) | 2.57001683 |
| 54 | nuclear-transcribed mRNA catabolic process, nonsense-mediated decay (GO:0000184) | 2.55291865 |
| 55 | ribosomal small subunit assembly (GO:0000028) | 2.54742932 |
| 56 | glycolipid catabolic process (GO:0019377) | 2.50730883 |
| 57 | protein localization to endosome (GO:0036010) | 2.49928605 |
| 58 | positive regulation of Cdc42 GTPase activity (GO:0043089) | 2.49650864 |
| 59 | detection of bacterium (GO:0016045) | 2.49518870 |
| 60 | ribonucleoprotein complex biogenesis (GO:0022613) | 2.49358769 |
| 61 | regulation of mast cell degranulation (GO:0043304) | 2.47932023 |
| 62 | chaperone mediated protein folding requiring cofactor (GO:0051085) | 2.47281798 |
| 63 | glucose catabolic process (GO:0006007) | 2.46491899 |
| 64 | positive regulation of syncytium formation by plasma membrane fusion (GO:0060143) | 2.43134552 |
| 65 | pyrimidine nucleotide catabolic process (GO:0006244) | 2.43093773 |
| 66 | regulation of necrotic cell death (GO:0010939) | 2.33775797 |
| 67 | positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling | 2.32106128 |
| 68 | deoxyribonucleotide biosynthetic process (GO:0009263) | 2.31258403 |
| 69 | cellular protein complex disassembly (GO:0043624) | 2.31253560 |
| 70 | regulation of leukocyte degranulation (GO:0043300) | 2.30819391 |
| 71 | translational initiation (GO:0006413) | 2.29407410 |
| 72 | deoxyribose phosphate catabolic process (GO:0046386) | 2.29073966 |
| 73 | cellular response to arsenic-containing substance (GO:0071243) | 2.28414305 |
| 74 | mitochondrial calcium ion transport (GO:0006851) | 2.27705062 |
| 75 | B cell mediated immunity (GO:0019724) | 2.26229450 |
| 76 | granulocyte activation (GO:0036230) | 2.25754100 |
| 77 | deoxyribonucleotide catabolic process (GO:0009264) | 2.25657979 |
| 78 | guanosine-containing compound biosynthetic process (GO:1901070) | 2.24945889 |
| 79 | aminoglycoside antibiotic metabolic process (GO:0030647) | 2.24446385 |
| 80 | regulation of early endosome to late endosome transport (GO:2000641) | 2.24322475 |
| 81 | nucleotide salvage (GO:0043173) | 2.23523175 |
| 82 | protein retention in ER lumen (GO:0006621) | 2.21193893 |
| 83 | glucose 6-phosphate metabolic process (GO:0051156) | 2.20566382 |
| 84 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 2.19565091 |
| 85 | proteasome assembly (GO:0043248) | 2.19120026 |
| 86 | oligosaccharide catabolic process (GO:0009313) | 2.18792494 |
| 87 | maintenance of protein localization in endoplasmic reticulum (GO:0035437) | 2.18600660 |
| 88 | myeloid dendritic cell differentiation (GO:0043011) | 2.17516032 |
| 89 | regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway | 2.16613507 |
| 90 | formation of translation preinitiation complex (GO:0001731) | 2.16345231 |
| 91 | detection of external biotic stimulus (GO:0098581) | 2.16278103 |
| 92 | nucleoside salvage (GO:0043174) | 2.16063524 |
| 93 | positive regulation of leukocyte degranulation (GO:0043302) | 2.15818916 |
| 94 | amino sugar catabolic process (GO:0046348) | 2.15700658 |
| 95 | antigen processing and presentation of peptide antigen via MHC class I (GO:0002474) | 2.15172031 |
| 96 | myeloid cell homeostasis (GO:0002262) | 2.14866560 |
| 97 | regulation of translational termination (GO:0006449) | 2.12782233 |
| 98 | translation (GO:0006412) | 2.12625043 |
| 99 | positive regulation of monocyte chemotaxis (GO:0090026) | 2.12156692 |
| 100 | macrophage activation involved in immune response (GO:0002281) | 2.12132491 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 3.18221044 |
| 2 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.82200787 |
| 3 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 2.82144487 |
| 4 | E2F7_22180533_ChIP-Seq_HELA_Human | 2.59008927 |
| 5 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.50927401 |
| 6 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 2.41347678 |
| 7 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.39664012 |
| 8 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 2.36967141 |
| 9 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 2.20436331 |
| 10 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 2.15685210 |
| 11 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 2.03678971 |
| 12 | ZNF263_19887448_ChIP-Seq_K562_Human | 2.03215677 |
| 13 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 2.02112658 |
| 14 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 2.02072167 |
| 15 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.92823698 |
| 16 | MYC_22102868_ChIP-Seq_BL_Human | 1.78004348 |
| 17 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.75339617 |
| 18 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.67960350 |
| 19 | * DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.67620083 |
| 20 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.66768840 |
| 21 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.66324423 |
| 22 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.65856045 |
| 23 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.65381516 |
| 24 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 1.63276469 |
| 25 | MYC_19030024_ChIP-ChIP_MESCs_Mouse | 1.59213480 |
| 26 | XRN2_22483619_ChIP-Seq_HELA_Human | 1.59091768 |
| 27 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.58349040 |
| 28 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 1.56327475 |
| 29 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 1.54786799 |
| 30 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.53716652 |
| 31 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.53555275 |
| 32 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 1.51326620 |
| 33 | * ETS1_20019798_ChIP-Seq_JURKAT_Human | 1.50071222 |
| 34 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.48130229 |
| 35 | DCP1A_22483619_ChIP-Seq_HELA_Human | 1.47154168 |
| 36 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 1.46794143 |
| 37 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.46057920 |
| 38 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.44638754 |
| 39 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 1.44260094 |
| 40 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 1.44218798 |
| 41 | ZFX_18555785_ChIP-Seq_MESCs_Mouse | 1.42415955 |
| 42 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.41689445 |
| 43 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.40937365 |
| 44 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.40827563 |
| 45 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 1.40057404 |
| 46 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.40035010 |
| 47 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.39963763 |
| 48 | E2F1_18555785_ChIP-Seq_MESCs_Mouse | 1.39046350 |
| 49 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.38989758 |
| 50 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.38633713 |
| 51 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.38388392 |
| 52 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 1.38107181 |
| 53 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.37828243 |
| 54 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.35355230 |
| 55 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.35102478 |
| 56 | * GABP_19822575_ChIP-Seq_HepG2_Human | 1.34884531 |
| 57 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.32490575 |
| 58 | KLF4_18555785_ChIP-Seq_MESCs_Mouse | 1.31752093 |
| 59 | CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 1.31053686 |
| 60 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.29366635 |
| 61 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.27739858 |
| 62 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.25803003 |
| 63 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.25100510 |
| 64 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.24272501 |
| 65 | MAF_26560356_Chip-Seq_TH1_Human | 1.24248698 |
| 66 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.24200647 |
| 67 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 1.23295883 |
| 68 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.22721941 |
| 69 | * FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 1.21246531 |
| 70 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.20745936 |
| 71 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.19933531 |
| 72 | * RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.19624045 |
| 73 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 1.19024205 |
| 74 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 1.18046569 |
| 75 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.14262459 |
| 76 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.13525855 |
| 77 | ATF3_27146783_Chip-Seq_COLON_Human | 1.13254120 |
| 78 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.13191153 |
| 79 | UTX_26944678_Chip-Seq_JUKART_Human | 1.12471658 |
| 80 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.12027505 |
| 81 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.11066939 |
| 82 | MAF_26560356_Chip-Seq_TH2_Human | 1.10827868 |
| 83 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 1.10557737 |
| 84 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.10465557 |
| 85 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.10253703 |
| 86 | CNOT3_19339689_ChIP-ChIP_MESCs_Mouse | 1.07442471 |
| 87 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.06714297 |
| 88 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.06374552 |
| 89 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 1.05982484 |
| 90 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.05352680 |
| 91 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.04725152 |
| 92 | * P68_20966046_ChIP-Seq_HELA_Human | 1.04584308 |
| 93 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.04314014 |
| 94 | CTCF_18555785_ChIP-Seq_MESCs_Mouse | 1.03044289 |
| 95 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 1.02789043 |
| 96 | POU5F1_18555785_ChIP-Seq_MESCs_Mouse | 1.02637205 |
| 97 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.01621921 |
| 98 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.01602383 |
| 99 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 1.00982850 |
| 100 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.00470312 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0005451_abnormal_body_composition | 3.66799071 |
| 2 | MP0003806_abnormal_nucleotide_metabolis | 3.18965723 |
| 3 | MP0005058_abnormal_lysosome_morphology | 3.12992290 |
| 4 | MP0003436_decreased_susceptibility_to | 2.85501849 |
| 5 | MP0003191_abnormal_cellular_cholesterol | 2.80081405 |
| 6 | MP0009840_abnormal_foam_cell | 2.79964756 |
| 7 | MP0002877_abnormal_melanocyte_morpholog | 2.52746976 |
| 8 | MP0008260_abnormal_autophagy | 2.40255852 |
| 9 | MP0001835_abnormal_antigen_presentation | 2.30794028 |
| 10 | MP0009333_abnormal_splenocyte_physiolog | 2.25166675 |
| 11 | MP0003303_peritoneal_inflammation | 2.20125505 |
| 12 | MP0009785_altered_susceptibility_to | 2.17788922 |
| 13 | MP0002148_abnormal_hypersensitivity_rea | 2.15480576 |
| 14 | MP0002419_abnormal_innate_immunity | 2.11219652 |
| 15 | MP0000858_altered_metastatic_potential | 2.06994082 |
| 16 | MP0005025_abnormal_response_to | 2.00449089 |
| 17 | MP0005464_abnormal_platelet_physiology | 1.99616795 |
| 18 | MP0006082_CNS_inflammation | 1.96243647 |
| 19 | MP0010234_abnormal_vibrissa_follicle | 1.87032185 |
| 20 | MP0004185_abnormal_adipocyte_glucose | 1.77360390 |
| 21 | MP0005000_abnormal_immune_tolerance | 1.76517928 |
| 22 | MP0000685_abnormal_immune_system | 1.72444948 |
| 23 | MP0002139_abnormal_hepatobiliary_system | 1.71789929 |
| 24 | MP0009379_abnormal_foot_pigmentation | 1.69791682 |
| 25 | MP0003724_increased_susceptibility_to | 1.65371209 |
| 26 | MP0000343_altered_response_to | 1.64863456 |
| 27 | MP0001853_heart_inflammation | 1.63278012 |
| 28 | MP0000490_abnormal_crypts_of | 1.63193977 |
| 29 | MP0003453_abnormal_keratinocyte_physiol | 1.62895041 |
| 30 | MP0002452_abnormal_antigen_presenting | 1.62522989 |
| 31 | MP0002723_abnormal_immune_serum | 1.55142072 |
| 32 | MP0003186_abnormal_redox_activity | 1.54610109 |
| 33 | MP0002796_impaired_skin_barrier | 1.53609766 |
| 34 | MP0001790_abnormal_immune_system | 1.53285199 |
| 35 | MP0005387_immune_system_phenotype | 1.53285199 |
| 36 | MP0001819_abnormal_immune_cell | 1.53098763 |
| 37 | MP0002420_abnormal_adaptive_immunity | 1.53007912 |
| 38 | MP0003172_abnormal_lysosome_physiology | 1.52730419 |
| 39 | MP0004947_skin_inflammation | 1.51217152 |
| 40 | MP0005671_abnormal_response_to | 1.51089582 |
| 41 | MP0003693_abnormal_embryo_hatching | 1.45989420 |
| 42 | MP0003075_altered_response_to | 1.43889182 |
| 43 | MP0008469_abnormal_protein_level | 1.43269257 |
| 44 | MP0009764_decreased_sensitivity_to | 1.42144228 |
| 45 | MP0001800_abnormal_humoral_immune | 1.41848702 |
| 46 | MP0001845_abnormal_inflammatory_respons | 1.40073036 |
| 47 | MP0010155_abnormal_intestine_physiology | 1.35739525 |
| 48 | MP0001533_abnormal_skeleton_physiology | 1.34607568 |
| 49 | MP0004957_abnormal_blastocyst_morpholog | 1.32798290 |
| 50 | MP0004233_abnormal_muscle_weight | 1.31390539 |
| 51 | MP0004858_abnormal_nervous_system | 1.30840753 |
| 52 | MP0003705_abnormal_hypodermis_morpholog | 1.30816711 |
| 53 | MP0005501_abnormal_skin_physiology | 1.29788089 |
| 54 | MP0006036_abnormal_mitochondrial_physio | 1.23025272 |
| 55 | MP0005319_abnormal_enzyme/_coenzyme | 1.22495524 |
| 56 | MP0002132_abnormal_respiratory_system | 1.20002339 |
| 57 | MP0003300_gastrointestinal_ulcer | 1.19534546 |
| 58 | MP0000716_abnormal_immune_system | 1.17823522 |
| 59 | MP0002398_abnormal_bone_marrow | 1.16696652 |
| 60 | MP0005360_urolithiasis | 1.14531905 |
| 61 | MP0002429_abnormal_blood_cell | 1.13934281 |
| 62 | MP0009278_abnormal_bone_marrow | 1.10010050 |
| 63 | MP0003566_abnormal_cell_adhesion | 1.08813336 |
| 64 | MP0000604_amyloidosis | 1.08332838 |
| 65 | MP0003123_paternal_imprinting | 1.06070265 |
| 66 | MP0004264_abnormal_extraembryonic_tissu | 1.06036619 |
| 67 | MP0003448_altered_tumor_morphology | 1.05841682 |
| 68 | MP0002405_respiratory_system_inflammati | 1.05038270 |
| 69 | MP0002998_abnormal_bone_remodeling | 1.04549514 |
| 70 | MP0001545_abnormal_hematopoietic_system | 1.04297701 |
| 71 | MP0005397_hematopoietic_system_phenotyp | 1.04297701 |
| 72 | MP0002722_abnormal_immune_system | 1.03463697 |
| 73 | MP0003828_pulmonary_edema | 1.01027638 |
| 74 | MP0003763_abnormal_thymus_physiology | 1.00236851 |
| 75 | MP0005166_decreased_susceptibility_to | 0.97626892 |
| 76 | MP0000609_abnormal_liver_physiology | 0.96995847 |
| 77 | MP0003111_abnormal_nucleus_morphology | 0.95576429 |
| 78 | MP0000689_abnormal_spleen_morphology | 0.95530542 |
| 79 | MP0000678_abnormal_parathyroid_gland | 0.95500431 |
| 80 | MP0004510_myositis | 0.94427665 |
| 81 | MP0001216_abnormal_epidermal_layer | 0.92116148 |
| 82 | MP0003656_abnormal_erythrocyte_physiolo | 0.91928957 |
| 83 | MP0003221_abnormal_cardiomyocyte_apopto | 0.91706478 |
| 84 | MP0008007_abnormal_cellular_replicative | 0.90943949 |
| 85 | MP0000465_gastrointestinal_hemorrhage | 0.89809275 |
| 86 | MP0005666_abnormal_adipose_tissue | 0.88517725 |
| 87 | MP0009763_increased_sensitivity_to | 0.87882717 |
| 88 | MP0005365_abnormal_bile_salt | 0.87012882 |
| 89 | MP0005023_abnormal_wound_healing | 0.85656395 |
| 90 | MP0005165_increased_susceptibility_to | 0.85350544 |
| 91 | MP0000750_abnormal_muscle_regeneration | 0.85315953 |
| 92 | MP0001873_stomach_inflammation | 0.83565336 |
| 93 | MP0000313_abnormal_cell_death | 0.83493159 |
| 94 | MP0001727_abnormal_embryo_implantation | 0.82774913 |
| 95 | MP0003077_abnormal_cell_cycle | 0.82147397 |
| 96 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.81498864 |
| 97 | MP0008932_abnormal_embryonic_tissue | 0.81441619 |
| 98 | MP0001849_ear_inflammation | 0.81278214 |
| 99 | MP0003866_abnormal_defecation | 0.80079762 |
| 100 | MP0008875_abnormal_xenobiotic_pharmacok | 0.79960744 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Abnormality of liposaccharide metabolism (HP:0010968) | 4.17863707 |
| 2 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 4.17863707 |
| 3 | Abnormality of glycolipid metabolism (HP:0010969) | 4.17863707 |
| 4 | Abnormality of macrophages (HP:0004311) | 3.98990223 |
| 5 | Eczematoid dermatitis (HP:0000976) | 3.41080475 |
| 6 | Recurrent abscess formation (HP:0002722) | 3.34011472 |
| 7 | Recurrent bacterial skin infections (HP:0005406) | 3.29639003 |
| 8 | Chronic obstructive pulmonary disease (HP:0006510) | 3.15210647 |
| 9 | Obstructive lung disease (HP:0006536) | 3.15210647 |
| 10 | Increased serum ferritin (HP:0003281) | 3.00037968 |
| 11 | Vertebral compression fractures (HP:0002953) | 2.91789935 |
| 12 | Increased cerebral lipofuscin (HP:0011813) | 2.84385055 |
| 13 | Ragged-red muscle fibers (HP:0003200) | 2.82672362 |
| 14 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.80029546 |
| 15 | Vacuolated lymphocytes (HP:0001922) | 2.79534548 |
| 16 | Petechiae (HP:0000967) | 2.67512920 |
| 17 | Hepatosplenomegaly (HP:0001433) | 2.67072710 |
| 18 | Purpura (HP:0000979) | 2.52830717 |
| 19 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 2.50301340 |
| 20 | Achilles tendon contracture (HP:0001771) | 2.47619820 |
| 21 | Progressive neurologic deterioration (HP:0002344) | 2.47156581 |
| 22 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.46834135 |
| 23 | Rough bone trabeculation (HP:0100670) | 2.44917829 |
| 24 | Increased muscle lipid content (HP:0009058) | 2.44315515 |
| 25 | Abnormality of the Achilles tendon (HP:0005109) | 2.42221205 |
| 26 | Systemic lupus erythematosus (HP:0002725) | 2.41709295 |
| 27 | Increased intramyocellular lipid droplets (HP:0012240) | 2.36949076 |
| 28 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 2.36482345 |
| 29 | Increased IgM level (HP:0003496) | 2.34216577 |
| 30 | Loss of speech (HP:0002371) | 2.34048637 |
| 31 | Urticaria (HP:0001025) | 2.33156072 |
| 32 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 2.31718854 |
| 33 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 2.31718854 |
| 34 | Mediastinal lymphadenopathy (HP:0100721) | 2.29557876 |
| 35 | Progressive muscle weakness (HP:0003323) | 2.26880455 |
| 36 | Microretrognathia (HP:0000308) | 2.25674612 |
| 37 | Axonal loss (HP:0003447) | 2.25668614 |
| 38 | Abnormality of iron homeostasis (HP:0011031) | 2.25624555 |
| 39 | Multiple enchondromatosis (HP:0005701) | 2.24794753 |
| 40 | Amyloidosis (HP:0011034) | 2.22740957 |
| 41 | Dysostosis multiplex (HP:0000943) | 2.19593173 |
| 42 | Hypertensive crisis (HP:0100735) | 2.19506542 |
| 43 | Abnormal mitochondria in muscle tissue (HP:0008316) | 2.19357784 |
| 44 | Upper motor neuron abnormality (HP:0002127) | 2.18497010 |
| 45 | Myositis (HP:0100614) | 2.18222822 |
| 46 | Renal Fanconi syndrome (HP:0001994) | 2.16405127 |
| 47 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.15936575 |
| 48 | Prolonged neonatal jaundice (HP:0006579) | 2.14533562 |
| 49 | Distal lower limb muscle weakness (HP:0009053) | 2.13488907 |
| 50 | Hypokinesia (HP:0002375) | 2.11856608 |
| 51 | Abnormal trabecular bone morphology (HP:0100671) | 2.08151077 |
| 52 | Decreased activity of cytochrome C oxidase in muscle tissue (HP:0003688) | 2.07030719 |
| 53 | Trismus (HP:0000211) | 2.00158347 |
| 54 | Deep venous thrombosis (HP:0002625) | 1.98149525 |
| 55 | Orchitis (HP:0100796) | 1.97539702 |
| 56 | Cellulitis (HP:0100658) | 1.97236945 |
| 57 | Recurrent skin infections (HP:0001581) | 1.96328308 |
| 58 | Thrombocytosis (HP:0001894) | 1.94926633 |
| 59 | Microvesicular hepatic steatosis (HP:0001414) | 1.94889123 |
| 60 | Bone pain (HP:0002653) | 1.94020481 |
| 61 | Pallor (HP:0000980) | 1.93139562 |
| 62 | Acute necrotizing encephalopathy (HP:0006965) | 1.90917193 |
| 63 | Rhabdomyolysis (HP:0003201) | 1.88009630 |
| 64 | Stomatitis (HP:0010280) | 1.86875948 |
| 65 | Myocardial infarction (HP:0001658) | 1.85070992 |
| 66 | Generalized aminoaciduria (HP:0002909) | 1.84779187 |
| 67 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 1.84485204 |
| 68 | Gingivitis (HP:0000230) | 1.84193083 |
| 69 | Abnormality of the distal phalanges of the toes (HP:0010182) | 1.83154124 |
| 70 | Distal lower limb amyotrophy (HP:0008944) | 1.82898222 |
| 71 | Meningitis (HP:0001287) | 1.80808604 |
| 72 | Personality changes (HP:0000751) | 1.80345023 |
| 73 | Macrocytic anemia (HP:0001972) | 1.80145137 |
| 74 | Hyperparathyroidism (HP:0000843) | 1.79827305 |
| 75 | Aplasia/Hypoplasia of the sacrum (HP:0008517) | 1.79496694 |
| 76 | Abnormality of cells of the erythroid lineage (HP:0012130) | 1.77115064 |
| 77 | Mitochondrial inheritance (HP:0001427) | 1.76335321 |
| 78 | Acute hepatic failure (HP:0006554) | 1.76049402 |
| 79 | Autoimmune thrombocytopenia (HP:0001973) | 1.74726180 |
| 80 | Pathologic fracture (HP:0002756) | 1.73777001 |
| 81 | Hypertriglyceridemia (HP:0002155) | 1.73618848 |
| 82 | Polygenic inheritance (HP:0010982) | 1.73512980 |
| 83 | Aplastic anemia (HP:0001915) | 1.73063712 |
| 84 | Nausea (HP:0002018) | 1.71973218 |
| 85 | Malnutrition (HP:0004395) | 1.71587930 |
| 86 | Neoplasm of head and neck (HP:0012288) | 1.71433855 |
| 87 | Esophageal neoplasm (HP:0100751) | 1.71433855 |
| 88 | Recurrent viral infections (HP:0004429) | 1.69969715 |
| 89 | Respiratory difficulties (HP:0002880) | 1.68137847 |
| 90 | Fasciculations (HP:0002380) | 1.67510385 |
| 91 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.67462246 |
| 92 | Recurrent fungal infections (HP:0002841) | 1.66865906 |
| 93 | Lipid accumulation in hepatocytes (HP:0006561) | 1.64976974 |
| 94 | Nail dystrophy (HP:0008404) | 1.64832452 |
| 95 | Abnormality of polysaccharide metabolism (HP:0011012) | 1.63235595 |
| 96 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 1.63235595 |
| 97 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 1.63235595 |
| 98 | Hepatocellular necrosis (HP:0001404) | 1.63090550 |
| 99 | Episodic fever (HP:0001954) | 1.62628719 |
| 100 | Gastrointestinal infarctions (HP:0005244) | 1.62553957 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | NME2 | 4.87468564 |
| 2 | IRAK3 | 3.96462329 |
| 3 | TESK2 | 3.25456749 |
| 4 | ERN1 | 3.02188994 |
| 5 | SMG1 | 2.28503886 |
| 6 | MAP2K3 | 2.15147393 |
| 7 | SCYL2 | 2.08522655 |
| 8 | MAP3K11 | 2.08298348 |
| 9 | ARAF | 2.08286603 |
| 10 | TESK1 | 2.06378060 |
| 11 | EPHA2 | 2.05275221 |
| 12 | TRIB3 | 2.03050888 |
| 13 | IRAK4 | 1.88070744 |
| 14 | PRPF4B | 1.84145772 |
| 15 | TAOK2 | 1.80267906 |
| 16 | MST1R | 1.62184359 |
| 17 | ABL2 | 1.59736209 |
| 18 | TYK2 | 1.59352681 |
| 19 | RIPK4 | 1.59229077 |
| 20 | PAK4 | 1.58956052 |
| 21 | TBK1 | 1.48667514 |
| 22 | MAP3K3 | 1.45484549 |
| 23 | PIM2 | 1.43923457 |
| 24 | BUB1 | 1.42651206 |
| 25 | SIK1 | 1.33399948 |
| 26 | MAP3K12 | 1.32028563 |
| 27 | MAP4K1 | 1.25586850 |
| 28 | BCKDK | 1.23960714 |
| 29 | KDR | 1.23951254 |
| 30 | EIF2AK1 | 1.23279306 |
| 31 | STK16 | 1.22122704 |
| 32 | VRK2 | 1.18522610 |
| 33 | TAOK1 | 1.16457685 |
| 34 | ZAP70 | 1.15043189 |
| 35 | BLK | 1.14604998 |
| 36 | LIMK1 | 1.11212983 |
| 37 | LRRK2 | 1.09493646 |
| 38 | PBK | 1.08504080 |
| 39 | MAP3K1 | 1.07986578 |
| 40 | CSK | 1.07022943 |
| 41 | IRAK2 | 1.05150782 |
| 42 | GRK6 | 1.04214025 |
| 43 | MOS | 0.99009898 |
| 44 | ICK | 0.97955790 |
| 45 | MAP3K13 | 0.95034944 |
| 46 | ILK | 0.92851749 |
| 47 | MAP3K14 | 0.92118444 |
| 48 | MAP3K8 | 0.91164699 |
| 49 | TTN | 0.90152746 |
| 50 | PDK2 | 0.88480288 |
| 51 | BRAF | 0.88346168 |
| 52 | SIK3 | 0.85849686 |
| 53 | KSR2 | 0.84911814 |
| 54 | RPS6KA4 | 0.84881845 |
| 55 | BMPR2 | 0.84781078 |
| 56 | PTK6 | 0.78180850 |
| 57 | PRKG2 | 0.77111741 |
| 58 | MATK | 0.74125525 |
| 59 | IKBKB | 0.72465226 |
| 60 | PDPK1 | 0.71127947 |
| 61 | CSF1R | 0.69485915 |
| 62 | RPS6KB2 | 0.67577234 |
| 63 | JAK3 | 0.64740318 |
| 64 | AURKA | 0.64415794 |
| 65 | CDK7 | 0.62314458 |
| 66 | MAPK11 | 0.60510241 |
| 67 | TGFBR2 | 0.59415935 |
| 68 | MAP3K6 | 0.57743255 |
| 69 | STK10 | 0.53481147 |
| 70 | BTK | 0.52727006 |
| 71 | PTK2 | 0.51493162 |
| 72 | PAK1 | 0.49973960 |
| 73 | MARK3 | 0.49946666 |
| 74 | SRPK1 | 0.49918979 |
| 75 | CDK19 | 0.49347053 |
| 76 | MAP3K9 | 0.49310932 |
| 77 | BMX | 0.45936268 |
| 78 | IKBKE | 0.44694369 |
| 79 | NEK1 | 0.42815068 |
| 80 | RAF1 | 0.42372930 |
| 81 | ERBB4 | 0.41678930 |
| 82 | CDK4 | 0.40270565 |
| 83 | EPHB1 | 0.40119762 |
| 84 | MAPKAPK2 | 0.39627816 |
| 85 | CDC7 | 0.39385227 |
| 86 | HCK | 0.39293021 |
| 87 | PRKCI | 0.39002640 |
| 88 | FGR | 0.37829012 |
| 89 | PDK1 | 0.37621981 |
| 90 | PKN2 | 0.36856781 |
| 91 | DAPK1 | 0.36655905 |
| 92 | CDK8 | 0.35167697 |
| 93 | LYN | 0.33021833 |
| 94 | LATS2 | 0.31717214 |
| 95 | AURKB | 0.30550324 |
| 96 | PRKCD | 0.30283970 |
| 97 | LMTK2 | 0.29983338 |
| 98 | IRAK1 | 0.29826128 |
| 99 | CLK1 | 0.29366802 |
| 100 | FES | 0.28735142 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Ribosome_Homo sapiens_hsa03010 | 3.12462747 |
| 2 | Proteasome_Homo sapiens_hsa03050 | 2.66791259 |
| 3 | Other glycan degradation_Homo sapiens_hsa00511 | 2.48216556 |
| 4 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 2.31633516 |
| 5 | DNA replication_Homo sapiens_hsa03030 | 2.02028405 |
| 6 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 1.92621414 |
| 7 | Sulfur relay system_Homo sapiens_hsa04122 | 1.91795065 |
| 8 | Lysosome_Homo sapiens_hsa04142 | 1.83592071 |
| 9 | Galactose metabolism_Homo sapiens_hsa00052 | 1.80801106 |
| 10 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 1.68309278 |
| 11 | Leishmaniasis_Homo sapiens_hsa05140 | 1.67391396 |
| 12 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.66951061 |
| 13 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.61261156 |
| 14 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.56623175 |
| 15 | Shigellosis_Homo sapiens_hsa05131 | 1.54819121 |
| 16 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.52526780 |
| 17 | Salmonella infection_Homo sapiens_hsa05132 | 1.51826617 |
| 18 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.51599904 |
| 19 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.51060276 |
| 20 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.49509570 |
| 21 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 1.46423378 |
| 22 | Bladder cancer_Homo sapiens_hsa05219 | 1.41240903 |
| 23 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.41125885 |
| 24 | Base excision repair_Homo sapiens_hsa03410 | 1.40562464 |
| 25 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 1.39452930 |
| 26 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 1.38117679 |
| 27 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.37009987 |
| 28 | Tuberculosis_Homo sapiens_hsa05152 | 1.31081557 |
| 29 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 1.29165071 |
| 30 | Parkinsons disease_Homo sapiens_hsa05012 | 1.27926325 |
| 31 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 1.26068121 |
| 32 | Legionellosis_Homo sapiens_hsa05134 | 1.23181435 |
| 33 | Phagosome_Homo sapiens_hsa04145 | 1.23171648 |
| 34 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.15615060 |
| 35 | Glutathione metabolism_Homo sapiens_hsa00480 | 1.13006050 |
| 36 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.11467559 |
| 37 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.10505354 |
| 38 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.10295251 |
| 39 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.08539943 |
| 40 | Carbon metabolism_Homo sapiens_hsa01200 | 1.07896030 |
| 41 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 1.04320150 |
| 42 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.04226268 |
| 43 | Allograft rejection_Homo sapiens_hsa05330 | 1.03847600 |
| 44 | Apoptosis_Homo sapiens_hsa04210 | 1.01523608 |
| 45 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.00377022 |
| 46 | Pertussis_Homo sapiens_hsa05133 | 0.99457731 |
| 47 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.98607607 |
| 48 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.98366085 |
| 49 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.96868023 |
| 50 | Influenza A_Homo sapiens_hsa05164 | 0.96089903 |
| 51 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.95623623 |
| 52 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.93441391 |
| 53 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.93151035 |
| 54 | Spliceosome_Homo sapiens_hsa03040 | 0.92910950 |
| 55 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.91600545 |
| 56 | Viral myocarditis_Homo sapiens_hsa05416 | 0.91245791 |
| 57 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.91201675 |
| 58 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.90352729 |
| 59 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.89314032 |
| 60 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.88476764 |
| 61 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.88176097 |
| 62 | Malaria_Homo sapiens_hsa05144 | 0.86388398 |
| 63 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.85513006 |
| 64 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.85495425 |
| 65 | Asthma_Homo sapiens_hsa05310 | 0.85172533 |
| 66 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.84474339 |
| 67 | Alzheimers disease_Homo sapiens_hsa05010 | 0.83724448 |
| 68 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.83434379 |
| 69 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.83147317 |
| 70 | Mismatch repair_Homo sapiens_hsa03430 | 0.82823537 |
| 71 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 0.81442843 |
| 72 | Huntingtons disease_Homo sapiens_hsa05016 | 0.77796397 |
| 73 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.77228017 |
| 74 | Prion diseases_Homo sapiens_hsa05020 | 0.75337023 |
| 75 | Measles_Homo sapiens_hsa05162 | 0.75238435 |
| 76 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.74498627 |
| 77 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.74136849 |
| 78 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.73009675 |
| 79 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.72535453 |
| 80 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.71329358 |
| 81 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.70210777 |
| 82 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.69939733 |
| 83 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.67572274 |
| 84 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 0.67273226 |
| 85 | Hepatitis B_Homo sapiens_hsa05161 | 0.67131161 |
| 86 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.64091844 |
| 87 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.63498339 |
| 88 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.63437718 |
| 89 | Hepatitis C_Homo sapiens_hsa05160 | 0.63409288 |
| 90 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.61430135 |
| 91 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.58440156 |
| 92 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.55670779 |
| 93 | Thyroid cancer_Homo sapiens_hsa05216 | 0.55208359 |
| 94 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.51810649 |
| 95 | Endocytosis_Homo sapiens_hsa04144 | 0.50807274 |
| 96 | RNA polymerase_Homo sapiens_hsa03020 | 0.49181694 |
| 97 | Nucleotide excision repair_Homo sapiens_hsa03420 | 0.47642029 |
| 98 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.47404860 |
| 99 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.45596241 |
| 100 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.42955662 |

